ADVANCED CLINICAL PHARMACOLOGY &
PSYCHIATRIC EMERGENCIES BOARD
REVIEW
Comprehensive 200-Question Examination with Detailed Rationales
Target Audience: Medical Residents, Pharmacists, Advanced
Practice Clinicians
Subject Matter: Neuroleptic Malignant Syndrome,
Psychopharmacology & Toxicology
Exam Format: 200 Multiple-Choice Questions with
Evidence-Based Rationales
,Question 1
A patient presents with acute onset of severe muscle rigidity, 'lead-pipe'
rigidity, hyperthermia (104°F), autonomic instability (labile blood
pressure, tachycardia), and elevated creatine kinase following the
administration of fluphenazine. What is the clinical diagnosis?
A) Serotonin Syndrome
B) Neuroleptic Malignant Syndrome (NMS)
C) Malignant Hyperthermia
D) Anticholinergic Toxicity
E) Acute Dystonic Reaction
Correct Answer: B) Neuroleptic Malignant Syndrome (NMS)
Rationale: Neuroleptic Malignant Syndrome (NMS) is a life-
threatening, idiosyncratic reaction to dopamine antagonists (such as
the typical antipsychotic fluphenazine). Classic tetrad features
include extreme hyperthermia, 'lead-pipe' muscle rigidity, autonomic
instability, and altered mental status, frequently accompanied by
marked creatine kinase (CK) elevation and leukocytosis.
Question 2
Clinical Vignette 2: A 42-year-old patient is evaluated for acute clinical
deterioration involving malignant hyperthermia features. Laboratory and
clinical findings require accurate differential diagnosis and management.
A) Primary diagnosis consistent with classic Malignant Hyperthermia
B) Alternative drug-induced toxicity mimicking Malignant
Hyperthermia
C) Idiopathic central nervous system infection
D) Acute metabolic encephalopathy
E) Primary autoimmune encephalitis
, Correct Answer: A) Primary diagnosis consistent with classic
Malignant Hyperthermia
Rationale: Detailed Rationale for Question 2: This case tests
advanced competency in recognizing and managing Malignant
Hyperthermia. Triggered by volatile halogenated anesthetics and
succinylcholine, caused by uncontrolled calcium release from the
sarcoplasmic reticulum via ryanodine receptor (RYR1) mutations.
Prompt identification, discontinuation of the offending agent, and
supportive care or targeted antidotes (e.g., dantrolene,
bromocriptine, or cyproheptadine) are paramount to clinical
recovery.
Question 3
Clinical Vignette 3: A 42-year-old patient is evaluated for acute clinical
deterioration involving lithium toxicity features. Laboratory and clinical
findings require accurate differential diagnosis and management.
A) Primary diagnosis consistent with classic Lithium Toxicity
B) Alternative drug-induced toxicity mimicking Lithium Toxicity
C) Idiopathic central nervous system infection
D) Acute metabolic encephalopathy
E) Primary autoimmune encephalitis
Correct Answer: A) Primary diagnosis consistent with classic
Lithium Toxicity
Rationale: Detailed Rationale for Question 3: This case tests
advanced competency in recognizing and managing Lithium Toxicity.
Acute toxicity presents with coarse tremors, ataxia, confusion, and
gastrointestinal distress. Chronic toxicity manifests with neurological
sequelae and nephrogenic diabetes insipidus. Prompt identification,
discontinuation of the offending agent, and supportive care or
, targeted antidotes (e.g., dantrolene, bromocriptine, or
cyproheptadine) are paramount to clinical recovery.
Question 4
Clinical Vignette 4: A 42-year-old patient is evaluated for acute clinical
deterioration involving antipsychotic-induced extrapyramidal symptoms
features. Laboratory and clinical findings require accurate differential
diagnosis and management.
A) Primary diagnosis consistent with classic Antipsychotic-Induced
Extrapyramidal Symptoms
B) Alternative drug-induced toxicity mimicking Antipsychotic-
Induced Extrapyramidal Symptoms
C) Idiopathic central nervous system infection
D) Acute metabolic encephalopathy
E) Primary autoimmune encephalitis
Correct Answer: A) Primary diagnosis consistent with classic
Antipsychotic-Induced Extrapyramidal Symptoms
Rationale: Detailed Rationale for Question 4: This case tests
advanced competency in recognizing and managing Antipsychotic-
Induced Extrapyramidal Symptoms. Dystonia, akathisia,
parkinsonism, and tardive dyskinesia resulting from striatal
dopamine D2 receptor antagonism. Prompt identification,
discontinuation of the offending agent, and supportive care or
targeted antidotes (e.g., dantrolene, bromocriptine, or
cyproheptadine) are paramount to clinical recovery.
Question 5
Clinical Vignette 5: A 42-year-old patient is evaluated for acute clinical
deterioration involving tricyclic antidepressant (tca) overdose features.
PSYCHIATRIC EMERGENCIES BOARD
REVIEW
Comprehensive 200-Question Examination with Detailed Rationales
Target Audience: Medical Residents, Pharmacists, Advanced
Practice Clinicians
Subject Matter: Neuroleptic Malignant Syndrome,
Psychopharmacology & Toxicology
Exam Format: 200 Multiple-Choice Questions with
Evidence-Based Rationales
,Question 1
A patient presents with acute onset of severe muscle rigidity, 'lead-pipe'
rigidity, hyperthermia (104°F), autonomic instability (labile blood
pressure, tachycardia), and elevated creatine kinase following the
administration of fluphenazine. What is the clinical diagnosis?
A) Serotonin Syndrome
B) Neuroleptic Malignant Syndrome (NMS)
C) Malignant Hyperthermia
D) Anticholinergic Toxicity
E) Acute Dystonic Reaction
Correct Answer: B) Neuroleptic Malignant Syndrome (NMS)
Rationale: Neuroleptic Malignant Syndrome (NMS) is a life-
threatening, idiosyncratic reaction to dopamine antagonists (such as
the typical antipsychotic fluphenazine). Classic tetrad features
include extreme hyperthermia, 'lead-pipe' muscle rigidity, autonomic
instability, and altered mental status, frequently accompanied by
marked creatine kinase (CK) elevation and leukocytosis.
Question 2
Clinical Vignette 2: A 42-year-old patient is evaluated for acute clinical
deterioration involving malignant hyperthermia features. Laboratory and
clinical findings require accurate differential diagnosis and management.
A) Primary diagnosis consistent with classic Malignant Hyperthermia
B) Alternative drug-induced toxicity mimicking Malignant
Hyperthermia
C) Idiopathic central nervous system infection
D) Acute metabolic encephalopathy
E) Primary autoimmune encephalitis
, Correct Answer: A) Primary diagnosis consistent with classic
Malignant Hyperthermia
Rationale: Detailed Rationale for Question 2: This case tests
advanced competency in recognizing and managing Malignant
Hyperthermia. Triggered by volatile halogenated anesthetics and
succinylcholine, caused by uncontrolled calcium release from the
sarcoplasmic reticulum via ryanodine receptor (RYR1) mutations.
Prompt identification, discontinuation of the offending agent, and
supportive care or targeted antidotes (e.g., dantrolene,
bromocriptine, or cyproheptadine) are paramount to clinical
recovery.
Question 3
Clinical Vignette 3: A 42-year-old patient is evaluated for acute clinical
deterioration involving lithium toxicity features. Laboratory and clinical
findings require accurate differential diagnosis and management.
A) Primary diagnosis consistent with classic Lithium Toxicity
B) Alternative drug-induced toxicity mimicking Lithium Toxicity
C) Idiopathic central nervous system infection
D) Acute metabolic encephalopathy
E) Primary autoimmune encephalitis
Correct Answer: A) Primary diagnosis consistent with classic
Lithium Toxicity
Rationale: Detailed Rationale for Question 3: This case tests
advanced competency in recognizing and managing Lithium Toxicity.
Acute toxicity presents with coarse tremors, ataxia, confusion, and
gastrointestinal distress. Chronic toxicity manifests with neurological
sequelae and nephrogenic diabetes insipidus. Prompt identification,
discontinuation of the offending agent, and supportive care or
, targeted antidotes (e.g., dantrolene, bromocriptine, or
cyproheptadine) are paramount to clinical recovery.
Question 4
Clinical Vignette 4: A 42-year-old patient is evaluated for acute clinical
deterioration involving antipsychotic-induced extrapyramidal symptoms
features. Laboratory and clinical findings require accurate differential
diagnosis and management.
A) Primary diagnosis consistent with classic Antipsychotic-Induced
Extrapyramidal Symptoms
B) Alternative drug-induced toxicity mimicking Antipsychotic-
Induced Extrapyramidal Symptoms
C) Idiopathic central nervous system infection
D) Acute metabolic encephalopathy
E) Primary autoimmune encephalitis
Correct Answer: A) Primary diagnosis consistent with classic
Antipsychotic-Induced Extrapyramidal Symptoms
Rationale: Detailed Rationale for Question 4: This case tests
advanced competency in recognizing and managing Antipsychotic-
Induced Extrapyramidal Symptoms. Dystonia, akathisia,
parkinsonism, and tardive dyskinesia resulting from striatal
dopamine D2 receptor antagonism. Prompt identification,
discontinuation of the offending agent, and supportive care or
targeted antidotes (e.g., dantrolene, bromocriptine, or
cyproheptadine) are paramount to clinical recovery.
Question 5
Clinical Vignette 5: A 42-year-old patient is evaluated for acute clinical
deterioration involving tricyclic antidepressant (tca) overdose features.
